Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture vs NSAIDs for AI-Induced Arthralgia in Breast Cancer Survivors
NCT04511832Completed
- Sponsor
- China Medical University Hospital
- Start
- Mar 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of diclofenac in arthralgia (3 arms), sponsored by China Medical University Hospital. Primary endpoint: Improvement in joint symptoms resulting from aromatase inhibitor and quality of life at 1 year. Started Mar 2018; status: completed.
02
Drugs
diclofenac
03
Conditions
arthralgia
Beyond the preview
Go deeper on NCT04511832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04511832.